Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus
- Conditions
- Normal Pressure Hydrocephalus
- Interventions
- Procedure: Endoscopic Third VentriculostomyProcedure: Ventriculo-Peritoneal Shunting
- Registration Number
- NCT03245138
- Lead Sponsor
- University Medicine Greifswald
- Brief Summary
An endoscopic third ventriculostomy is considered to be successful in idiopathic normal pressure hydrocephalus (iNPH) in some literature reports, but there is a lack of high quality data. The aim of the present study is to compare the treatment options of iNPH (Endoscopic third ventriculostomy versus ventriculo-peritoneal shunt) in a randomized, controlled, multicenter study.
- Detailed Description
The traditional treatment for communicating hydrocephalus is a ventriculo-peritoneal shunt insertion and the endoscopic third ventriculostomy (ETV) is reserved for patients with obstructive hydrocephalus. However, in the last decade several reports highlighted an success of an ETV in communicating hydrocephalus as well. Thus, the aim of the present study is to compare ventriculo-peritoneal shunting against ETV in patients with an idiopathic normal pressure hydrocephalus, an subset of communicating hydrocephalus, in a randomized, controlled multicenter study.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Age over 50 years
- gait disturbances typical for iNPH
- symptoms Duration less than 36months
- exclusion of obstructive hydrocephalus
- positive spinal TAP-test
- no informed consent
- malignant disease
- other diseases of the CNS (Parkinson, dementia)
- secondary communicating hydrocephalus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description endoscopic third ventriculostomy Endoscopic Third Ventriculostomy endoscopic third ventriculostomy for the treatment of iNPH ventricular peritoneal shunt Ventriculo-Peritoneal Shunting Insertion of a ventriculo-peritoneal Shunt for the treatment of iNPH
- Primary Outcome Measures
Name Time Method Recovery Index 1 year Improvment of at least 2 points
Kiefer Index 1 year Improvment of at least 2 points
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
University Medicine Greifswald
🇩🇪Greifswald, Germany
Klinikum Neubrandenburg
🇩🇪Neubrandenburg, Germany
University Medicine Göttingen
🇩🇪Göttingen, Germany